| 000 | 01906 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250516152742.0 | ||
| 264 | 0 | _c20140311 | |
| 008 | 201403s 0 0 eng d | ||
| 022 | _a1399-0012 | ||
| 024 | 7 |
_a10.1111/ctr.12142 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTaber, Tim | |
| 245 | 0 | 0 |
_aThe effectiveness of the combination of rituximab and high-dose immunoglobulin in the immunomodulation of sensitized kidney transplant candidates. _h[electronic resource] |
| 260 |
_bClinical transplantation _c |
||
| 300 |
_aE375-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use |
| 650 | 0 | 4 | _aDesensitization, Immunologic |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGraft Rejection _ximmunology |
| 650 | 0 | 4 |
_aHLA Antigens _ximmunology |
| 650 | 0 | 4 | _aHistocompatibility Testing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _ximmunology |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 | _aImmunomodulation |
| 650 | 0 | 4 |
_aIsoantibodies _xblood |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _ximmunology |
| 650 | 0 | 4 | _aKidney Transplantation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMujtaba, Muhammad Ahmad | |
| 700 | 1 | _aGoggins, William | |
| 700 | 1 | _aHiggins, Nancy | |
| 700 | 1 | _aSharfuddin, Asif | |
| 700 | 1 | _aYaqub, Muhammad Sohail | |
| 700 | 1 | _aMishler, Dennis | |
| 700 | 1 | _aBook, Benita | |
| 700 | 1 | _aChen, Jeanne | |
| 700 | 1 | _aLobashevsky, Andrew | |
| 773 | 0 |
_tClinical transplantation _gvol. 27 _gno. 4 _gp. E375-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/ctr.12142 _zAvailable from publisher's website |
| 999 |
_c22793565 _d22793565 |
||